|1.||Raue, Friedhelm: 5 articles (01/2015 - 11/2004)|
|2.||Wells, Samuel A: 5 articles (08/2013 - 09/2005)|
|3.||Frank-Raue, Karin: 4 articles (01/2015 - 06/2010)|
|4.||Dralle, Henning: 4 articles (03/2013 - 11/2004)|
|5.||Nosé, Vânia: 4 articles (04/2011 - 01/2008)|
|6.||Machens, Andreas: 3 articles (03/2013 - 11/2004)|
|7.||Kawai, Kumi: 3 articles (04/2006 - 05/2003)|
|8.||Pierotti, Marco A: 3 articles (04/2006 - 04/2004)|
|9.||Murakumo, Yoshiki: 3 articles (04/2006 - 05/2003)|
|10.||Takahashi, Masahide: 3 articles (04/2006 - 05/2003)|
|1.||Multiple Endocrine Neoplasia Type 2a (MEN 2)
11/01/2011 - "The aim of this study is to characterize clinically and molecularly 7 Cypriot patients with familial medullary thyroid carcinoma (FMTC) and 1 with MEN2A and also to determine the allelic frequencies of the RET variants G691S and S904S. "
07/01/2014 - "RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma."
08/01/2013 - "Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update."
01/01/2013 - "Familial medullary thyroid cancer is now viewed as a phenotypic variant of MEN2A with decreased penetrance for PHEO and PHPT rather than a distinct entity. "
01/01/2011 - "We set out to demonstrate a suitable example of genetic diagnosis of MEN 2A/FMTC (multiple endocrine neoplasia type 2/familial medullary thyroid carcinoma) using this approach. "
|2.||Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
03/31/1990 - "The study contributed to the diagnosis of multiple endocrine neoplasia type IIa, whereas the condition had been diagnosed for 6 years as familial medullary thyroid carcinoma, without phaechromocytoma. "
01/01/2013 - "Hereditary MTC appears as part of the multiple endocrine neoplasia syndrome type 2A or 2B, or familial medullary thyroid cancer. "
01/01/2012 - "Some may occur spontaneously or can be associated with Multiple Endocrine Neoplasia syndromes, or Familial Medullary Thyroid Cancer syndrome. "
03/01/2009 - "Activating mutations in the Ret proto-oncogene are responsible for occurrence of multiple endocrine neoplasia (MEN) type 2A and 2B, and familial medullary thyroid carcinoma (FMTC). "
09/01/2008 - "It may occur either sporadically (75%) or in familial forms (25%) in familial medullary thyroid carcinoma and multiple endocrine neoplasia types 2A and 2B. "
01/01/2003 - "[Study of RET protooncogene in multiple endocrine neoplasm 2A and in familial medullary thyroid carcinoma. "
01/01/2013 - "Medullary thyroid cancers can present sporadically, with other endocrine tumors, as in the complex of multiple endocrine neoplasias 1, 2A, or 2B, or as familial medullary thyroid cancer. "
04/01/2012 - "Familial medullary thyroid cancer is a variant of MEN-2 in which individuals affected develop only this neoplasm without other manifestations of MEN-2. "
11/10/2000 - "Genetic diagnostic is a safe and reliable predictive test for familial medullary thyroid cancer and should be carried out in any individual with this cancer. "
02/01/1997 - "Since MTC can also occur in a sporadic form and as familial medullary thyroid carcinoma, this neoplasm offers a unique opportunity to investigate the difference of origin, if any, between the sporadic and the hereditary forms of a tumor. "
|4.||Hirschsprung Disease (Hirschsprung's Disease)
01/01/2014 - "An extended family with familial medullary thyroid carcinoma and Hirschsprung's disease."
06/01/2005 - "A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease."
01/01/1997 - "Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting."
01/01/2012 - "Other RET mutations cause MEN 2A syndrome, familial medullary thyroid carcinoma, or Hirschsprung's disease. "
12/01/2009 - "Activating germline RET mutations are presented in patients with familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia (MEN) types 2A and 2B, whereas inactivating germline mutations in patients with Hirschsprung's disease (HSCR). "
01/01/1975 - "Natural history of the familial medullary thyroid carcinoma-pheochromocytoma syndrome and the identification of preneoplastic stages by screening studies: a five-year report."
01/01/1974 - "Familial medullary thyroid carcinoma and pheochromocytoma: epidemiologic investigations."
04/01/2012 - "On the basis of differences in variable expression of pheochromocytomas, hyperparathyroidism, and other clinical features, MEN-2 is divided into three clinical variants, referred to as MEN-2A, MEN-2B and familial medullary thyroid cancer. "
01/01/1991 - "Finally, MTC is transmitted in an autosomal dominant pattern in some families without associated pheochromocytomas or parathyroid hyperplasia (familial medullary thyroid carcinoma, MTC1(2). "
11/01/1971 - "Familial medullary thyroid carcinoma, pheochromocytoma, and parathyroid adenoma (Sipple's syndrome). "
|1.||Calcitonin (Calcitonin, Eel)
|5.||Protein-Tyrosine Kinases (Tyrosine Kinase)
|6.||tyrosine receptor (receptor, tyrosine)
|7.||medullary Thyroid cancer
|8.||DNA (Deoxyribonucleic Acid)
|9.||papillary Thyroid cancer